Risperidone
ریسپریدون
🧠 Nervous SystemAtypical antipsychotic
Market / country: 🇺🇸 USA
Risperdal (US)
🧮 Dose calculator
Irritability associated with autistic disorder · Regimen source: FDA Risperdal · 2.3FDA Risperdal · 1.3
- • After a minimum of 4 days increase to the recommended dose (<20 kg: 0.5 mg/day; ≥20 kg: 1 mg/day) and maintain for at least 14 days; further increases at intervals of ≥2 weeks. FDA Risperdal · 2.3
- • Effective range 0.5–3 mg/day. No dosing data below 15 kg. Total daily dose once daily, or half twice daily. FDA Risperdal · 2.3
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Known hypersensitivity to risperidone, paliperidone or any excipient. FDA Risperdal · 4
Warnings
- • Boxed warning: increased mortality in elderly patients with dementia-related psychosis; not approved for this use. FDA Risperdal · Boxed WarningFDA Risperdal · 5.1
- • Neuroleptic malignant syndrome FDA Risperdal · 5.3
- • Tardive dyskinesia FDA Risperdal · 5.4
- • Metabolic changes FDA Risperdal · 5.5
- • Hyperprolactinemia FDA Risperdal · 5.6
- • Orthostatic hypotension FDA Risperdal · 5.7
- • Falls FDA Risperdal · 5.8
Monitoring
- • Metabolic monitoring (glucose, lipids, weight) FDA Risperdal · 5.5
Renal adjustment
- • eGFR < 30: Severe renal impairment (Clcr <30): start 0.5 mg twice daily; increase by ≤0.5 mg twice daily; above 1.5 mg twice daily at intervals of ≥1 week. FDA Risperdal · 2.4
Formulations
- 1 mg / mL oral solution — solution 🇺🇸 USA FDA Risperdal · 3
- 0.5 mg tablet — tablet 🇺🇸 USA FDA Risperdal · 3
- 1 mg tablet — tablet 🇺🇸 USA FDA Risperdal · 3
- 2 mg tablet — tablet 🇺🇸 USA FDA Risperdal · 3
- 3 mg tablet — tablet 🇺🇸 USA FDA Risperdal · 3
- 4 mg tablet — tablet 🇺🇸 USA FDA Risperdal · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Risperdal · 8.1
“Risk Summary Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery (see Clinical Considerations ) .”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Risperdal · 8.2
“Risk Summary Limited data from published literature reports the presence of risperidone and its metabolite, 9-hydroxyrisperidone, in human breast milk at relative infant dose ranging between 2.3% and 4.7% of the maternal weight-adjusted dosage.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Risperdal · 8.4
“Safety and effectiveness of RISPERDAL in children less than 13 years of age with schizophrenia have not been established.”
- 👴 Older adultsDangerous / avoid
Label: serious warning or avoid in older adults. FDA Risperdal · Boxed Warning
“Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.”
- ⚥ Females & males of reproductive potentialUse with caution
Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Risperdal · 8.3
“Infertility Females Based on the pharmacologic action of risperidone (D 2 receptor antagonism), treatment with RISPERDAL may result in an increase in serum prolactin levels , which may lead to a reversible reduction in fertility in females of reproductive potential [see Warnings and Precautions (5.6) ].”
🔗 Reference links
- FDA (approval record)NDA020272
- DailyMed (FDA label)FDA Risperdal
- MedlinePlus (NIH)RisperidoneRisperidone Injection
- WHO ATC/DDDN05AX08
- Darooyab (Iran)Risperidone
🇮🇷 Registered in Iran Darooyab · G-1343/Risperidone
Dosage forms with Iranian generic codes, per Darooyab.
- 01773 · RISPERIDONE 1MG TAB · قرص ریسپریدون ۱ میلیگرم
- 16293 · RISPERIDONE 1MG/ML SYRUP · شربت ریسپریدون ۱ میلیگرم / میلیلیتر
- 08127 · RISPERIDONE 25MG LA INJ · فرآورده تزریقی ریسپریدون ۲۵ میلیگرم طولانیاثر
- 01774 · RISPERIDONE 2MG TAB · قرص ریسپریدون ۲ میلیگرم
- 19736 · RISPERIDONE 37.5MG LA INJ · فرآورده تزریقی ریسپریدون ۳۷٫۵ میلیگرم طولانیاثر
- 01869 · RISPERIDONE 3MG TAB · قرص ریسپریدون ۳ میلیگرم
- 01870 · RISPERIDONE 4MG TAB · قرص ریسپریدون ۴ میلیگرم
- 50088 · RISPERIDONE SOLUTION ORAL 1 mg/1mL 100 mL · محلول خوراکی ریسپریدون ۱ میلیگرم / ۱ میلیلیتر ۱۰۰ میلیلیتر
- 50996 · RISPERIDONE INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE PARENTERAL 50 mg · پودر تزریقی ریسپریدون ۵۰ میلیگرم
- 52191 · RISPERIDONE SOLUTION ORAL 1 mg/1mL 30 mL · محلول خوراکی ریسپریدون ۱ میلیگرم / ۱ میلیلیتر ۳۰ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Risperdal · 3FDA Risperdal · 2.3FDA Risperdal · 1.3FDA Risperdal · 2.1FDA Risperdal · 8.4FDA Risperdal · 2.2FDA Risperdal · 4FDA Risperdal · Boxed WarningFDA Risperdal · 5.1FDA Risperdal · 5.3FDA Risperdal · 5.4FDA Risperdal · 5.5FDA Risperdal · 5.6FDA Risperdal · 5.7FDA Risperdal · 5.8FDA Risperdal · 2.4FDA Risperdal · 8.1FDA Risperdal · 8.2FDA Risperdal · 8.3FDA Risperdal · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1343/Risperidone
- Clinical review⚠ Unverified